Jun Pang-Jun

No. 628 Zhenyuan Road
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation.

CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation.

Journal: Journal of translational medicine

Published: April 04, 2026

Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy.

Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy.

Journal: Biomaterials

Published: December 08, 2025

VEGF-C maturation mediated by CircFOCAD-orchestrated CCBE1 and ADAM10 expression in nuclear-cytoplasmic synergy drives lymphatic metastasis.

VEGF-C maturation mediated by CircFOCAD-orchestrated CCBE1 and ADAM10 expression in nuclear-cytoplasmic synergy drives lymphatic metastasis.

Journal: Oncogene

Published: November 04, 2025

High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contacts.

High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contacts.

Journal: Cancer letters

Published: July 12, 2025

Targeting YAP1-CD70 axis potentiates the efficacy of anti-PD-1 therapy in prostate cancer.

Targeting YAP1-CD70 axis potentiates the efficacy of anti-PD-1 therapy in prostate cancer.

Journal: Biomarker research

Published: July 01, 2025

Targeting metalloptosis in tumor therapy: from molecular mechanisms to application of metal nanoparticles.

Targeting metalloptosis in tumor therapy: from molecular mechanisms to application of metal nanoparticles.

Journal: Molecular cancer

Published: March 31, 2025

Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.

Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.

Journal: Journal of nanobiotechnology

Published: February 28, 2025

A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.

A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.

Journal: Journal of health, population, and nutrition

Published: February 27, 2025

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

Journal: Oncogene

Published: February 13, 2025

Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages.

Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 17, 2025

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: November 26, 2024

Interpretable multiphasic CT-based radiomic analysis for preoperatively differentiating benign and malignant solid renal tumors: a multicenter study.

Interpretable multiphasic CT-based radiomic analysis for preoperatively differentiating benign and malignant solid renal tumors: a multicenter study.

Journal: Abdominal radiology (New York)

Published: March 08, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026